High prolactin, or hyperprolactinemia, is most often treated with medication that lowers prolactin levels effectively in 60 to 90% of patients. Normal prolactin sits below 20 ng/mL for males and below 25 ng/mL for non-pregnant females. Treatment depends on the cause: a small pituitary tumor, a side effect of medication, or sometimes no identifiable trigger at all. The right approach varies, but most people see their levels normalize without surgery.
Dopamine Agonist Medications
The first-line treatment for high prolactin caused by a pituitary tumor (prolactinoma) is a class of drugs called dopamine agonists. These work by mimicking dopamine, a brain chemical that naturally suppresses prolactin release. The two most commonly used are cabergoline and bromocriptine, and they do more than just lower hormone levels. They also shrink pituitary tumors in the majority of cases.
Cabergoline is generally preferred. It normalizes prolactin in a higher percentage of patients, shrinks tumors in over 80% of cases (compared to about 60% with bromocriptine), and causes fewer side effects. It’s also more convenient, typically taken once or twice a week rather than daily. Bromocriptine is the older option. Its most common side effects are nausea and vomiting, which can be managed by starting at a low dose and taking it with food. Cabergoline can cause the same issues but does so less often.
One concern with cabergoline is a link to heart valve problems, but this was observed in Parkinson’s disease patients taking much higher doses (3 to 5 mg per day). The doses used for prolactin management are significantly lower. Your prescriber will monitor prolactin levels every one to two months initially, then every three to six months for the first couple of years. MRI scans to check tumor size are typically done about a year after starting treatment, then less frequently depending on tumor size.
When High Prolactin Is a Drug Side Effect
Antipsychotic medications are one of the most common non-tumor causes of elevated prolactin. If you’re on an antipsychotic and your prolactin is high, treatment decisions balance the hormone problem against the risk of destabilizing your mental health. There are several strategies, and they’re usually tried in a stepwise fashion.
The simplest first step is reducing the antipsychotic dose, since elevated prolactin from these drugs tends to be dose-related. If that’s not enough or isn’t safe, switching to a medication less likely to raise prolactin is the next option. Aripiprazole, clozapine, quetiapine, and olanzapine are all less frequently associated with this side effect. Switching should be done gradually, cross-tapering from one drug to the other rather than stopping abruptly.
If switching medications isn’t practical, adding a low dose of aripiprazole to the existing regimen is remarkably effective. Because aripiprazole partially activates dopamine receptors, it counteracts the prolactin-raising effect of the other antipsychotic. This approach normalizes prolactin levels in up to 79% of patients, and a dose as low as 5 mg per day is usually sufficient. Adding cabergoline or bromocriptine is another option, though it’s generally reserved for situations where other strategies haven’t worked.
Surgery for Pituitary Tumors
Surgery isn’t the default treatment for prolactinomas because medication works so well, but it becomes a serious option when drugs aren’t tolerated or don’t bring prolactin down far enough. It’s also considered when the tumor is small and well-positioned enough that a surgeon can likely remove it completely.
The procedure is called transsphenoidal surgery, performed through the nose and sinuses to reach the pituitary gland without opening the skull. For smaller, less invasive tumors, the results are strong: biochemical remission (meaning prolactin returns to normal) occurs in about 75% of patients. For larger tumors that extend into surrounding structures, remission drops to around 22%. Complication rates are low, and no deaths were reported in a large review of over 1,000 surgical patients. Recovery typically involves a short hospital stay and a few weeks before returning to normal activity.
Radiation as a Last Resort
Stereotactic radiosurgery, a highly focused form of radiation, is reserved for prolactinomas that don’t respond to medication and can’t be fully removed with surgery. It works, but slowly. Prolactin levels normalize in about 28% of patients by three years, 41% by five years, and 54% by eight years. Because of this long timeline, most patients continue dopamine agonist medication while waiting for the radiation’s full effect.
Treating High Prolactin During Pregnancy
High prolactin is a common cause of infertility because it disrupts ovulation. The good news is that dopamine agonists are effective at restoring fertility, and neither cabergoline nor bromocriptine has been linked to increased rates of miscarriage, birth defects, or pregnancy complications like preterm delivery.
For women with small prolactinomas, the standard approach is to stop the dopamine agonist once pregnancy is confirmed. By the time most women get a positive test, the fetus has already been exposed to the medication for about two weeks, and the available evidence shows no risk from that early exposure. Small tumors rarely cause problems during pregnancy, so ongoing treatment usually isn’t needed.
After delivery, dopamine agonist therapy is held until breastfeeding is finished, since these drugs suppress lactation. The one exception is women experiencing visual problems from tumor growth. In that case, restarting medication takes priority and breastfeeding is not recommended.
Lifestyle and Herbal Approaches
Chasteberry (Vitex agnus-castus) is the herbal supplement with the most research behind it for prolactin. It contains compounds that interact with dopamine receptors in the pituitary gland, mimicking the same mechanism as prescription dopamine agonists, just far more weakly. In one study of women with mild hyperprolactinemia, 40 mg daily of chasteberry extract lowered prolactin levels comparably to bromocriptine over three months. Other small studies using around 20 mg daily showed modest prolactin reductions in women with mildly elevated levels.
The evidence has real limitations, though. Most studies were small, and results at very low doses (under 120 mg of the raw herb) actually showed prolactin going up rather than down in one trial of healthy men. Single doses had no measurable effect at all. Chasteberry may be reasonable for mild, symptom-free elevations, but it’s not a substitute for dopamine agonist therapy when prolactin is significantly elevated or a tumor is present.
Stress, sleep deprivation, and intense exercise can all temporarily raise prolactin, which is why a single mildly elevated blood test is usually repeated before starting treatment. Addressing these factors won’t resolve a true prolactinoma, but they can help avoid unnecessary treatment for transient spikes.